Eye Laser Industry - VISX and Summit BEAM Info Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Daryl Gresham who wrote (34)	8/29/1996 9:17:00 PM
From: AgAuUSA	of 178

Daryl, Summit claims it has paid the per pt royalty on machines sold. Dispute is relating to amts to be paid per pt per machine (and possibly to the machines sold before VISX approvals). Still sounds like VISX is unreasonable in going straight to court and not first asking for arbitration. Bottom line, depositions may force court to restructure or dissolve the partnership--bad for both cos. Sounds like Summit is doing a fair business in eye surgery. Indication to me is that VISX is either unreasonable or having a cash flow problem or both. Don't plan to add VISX till stock under $10. Plan to hold BEAM and add on further weakness. Can you give any analytic input to compare astigmatism tx. Interested in success outcomes and pt acceptance and limits. Both cos are great holds....question is price and time to profitability. Thanx, Greg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next